Search for: "John Jenkins"
Results 941 - 960
of 1,750
Sorted by Relevance
|
Sort by Date
31 Mar 2023, 3:30 am
– John Jenkins [read post]
22 May 2023, 3:30 am
– John Jenkins [read post]
18 Apr 2022, 3:15 am
– John Jenkins [read post]
19 Apr 2022, 3:15 am
– John Jenkins [read post]
29 Mar 2011, 7:58 am
The otherwise lucid Sally Jenkins from the Washington Post becomes unhinged on the subject, urging this exact type of lawsuit. [read post]
7 Jul 2023, 3:15 am
– John Jenkins [read post]
30 Mar 2022, 3:15 am
– John Jenkins [read post]
11 Oct 2022, 9:15 pm
– John Jenkins [read post]
12 Oct 2022, 9:01 pm
Clever… – John Jenkins [read post]
23 Sep 2021, 3:30 am
– John Jenkins [read post]
27 Sep 2017, 3:00 am
– John Jenkins [read post]
23 Sep 2022, 3:30 am
– John Jenkins [read post]
31 Oct 2008, 3:17 pm
John Jenkins, director of the Office of New Drugs, wrote in a 2003 memo: "The premise of the basis for much of the argument for why we are proposing to invoke preemption seems to be based on a false assumption that the FDA-approved labeling is fully accurate and up-to-date in a real-time basis. [read post]
4 Aug 2023, 3:30 am
– John Jenkins [read post]
29 Nov 2010, 1:59 pm
The director of a branch of the FDA that determines risk to benefit profile commented on the panel's updated opinion on medications like Darvocet and Darvon: "The FDA is pleased by Xanodyne's decision to voluntarily remove its products from the U.S. market," said John Jenkins, M.D., director of the Office of New Drugs in the FDA's Center for Drug Evaluation and Research (CDER). [read post]
19 Sep 2022, 3:15 am
– John Jenkins [read post]
9 Mar 2022, 9:01 pm
– John Jenkins [read post]
11 Dec 2023, 3:30 am
– John Jenkins [read post]
2 Nov 2008, 11:10 am
In 2003, John Jenkins, a top official in the FDA’s drug approval section stated that much of the argument for preemption is based on a false assumption that the FDA approved labeling is fully accurate and up-to-date in a real time basis. [read post]
20 Apr 2022, 3:30 am
– John Jenkins [read post]
